HENG Yuan. Efficacy and safety of targeted therapy for breast cancer with positive anti-human epidermal growth factor receptor 2[J]. Journal of Clinical Medicine in Practice, 2018, (3): 56-58. DOI: 10.7619/jcmp.201803015
|
Citation:
|
HENG Yuan. Efficacy and safety of targeted therapy for breast cancer with positive anti-human epidermal growth factor receptor 2[J]. Journal of Clinical Medicine in Practice, 2018, (3): 56-58. DOI: 10.7619/jcmp.201803015
|
HENG Yuan. Efficacy and safety of targeted therapy for breast cancer with positive anti-human epidermal growth factor receptor 2[J]. Journal of Clinical Medicine in Practice, 2018, (3): 56-58. DOI: 10.7619/jcmp.201803015
|
Citation:
|
HENG Yuan. Efficacy and safety of targeted therapy for breast cancer with positive anti-human epidermal growth factor receptor 2[J]. Journal of Clinical Medicine in Practice, 2018, (3): 56-58. DOI: 10.7619/jcmp.201803015
|
DownLoad: